Product
Nanrilkefusp alfa
1 clinical trial
1 indication
Indication
Colorectal CancerClinical trial
A Phase 2, Open-label, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of SOT101 in Combination With Cetuximab in Patients With RAS Wild-type Colorectal CancerStatus: Active (not recruiting), Estimated PCD: 2024-08-01